{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:50:38Z","timestamp":1790805038100,"version":"4.1.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Intestinal fibrosis is a common and serious complication of inflammatory bowel diseases, often leading to strictures that require endoscopic or surgical intervention. Despite advances in anti-inflammatory therapies, effective antifibrotic treatments is currently not available. Therefore, new treatment methods for intestinal fibrosis are sought with the endocannabinoid system (ECS) as a potential therapeutic target. Cannabinoid receptors 1 and 2 (CB1\/2) are classic receptors of the ES involved in the modulation of intestinal inflammation and permeability of the mucosal barrier. Experimental evidence from liver and lung models suggests that CB1 receptor activation promotes fibrosis through enhancement of the TGF-\u03b2\/Smad pathway, interaction with the renin-angiotensin system, and upregulation of profibrotic markers, such as collagen and \u03b1-SMA. In contrast, CB2 receptor signaling appears to exert protective effects by limiting inflammation, fibroblast activation, and extracellular matrix deposition. Recent findings also suggest cross-talk between cannabinoid signaling and platelet-derived growth factor pathways, which are key drivers of myofibroblast proliferation and fibrogenesis. Although these mechanisms are well-established in hepatic, pulmonary and skin fibrosis, data from small and large intestine is scarce. However, direct evidence in intestinal fibrosis is scarce, representing a major knowledge gap. Elucidating ECS mechanisms in the alimentary tract could enable targeted antifibrotic strategies, complement current therapies, and reduce progression to fibrostenotic disease.<\/jats:p>","DOI":"10.3389\/fphar.2025.1669951","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T04:10:31Z","timestamp":1759464631000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["The endocannabinoid system as a therapeutic target in intestinal fibrosis"],"prefix":"10.3389","volume":"16","author":[{"given":"Zofia","family":"Misztal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Ka\u015bniewska-Kosi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Wo\u0142yniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Ma\u0142ecka-Wojciesko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Fabisiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/nu15010178","article-title":"Low-dose administration of cannabigerol attenuates inflammation and fibrosis associated with methionine\/choline deficient diet-induced NASH model via modulation of cannabinoid receptor","volume":"15","author":"Aljobaily","year":"2022","journal-title":"Nutrients"},{"key":"B2","first-page":"263","article-title":"Frailty in patients with inflammatory bowel disease","volume":"17","author":"Ananthakrishnan","year":"2021","journal-title":"Gastroenterol. Hepatol. (N Y)."},{"key":"B3","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/labinvest.2015.67","article-title":"The role of iNOS in cholesterol-induced liver fibrosis","volume":"95","author":"Anavi","year":"2015","journal-title":"Lab. Invest."},{"key":"B4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1755-1536-7-5","article-title":"Medical therapy of stricturing crohn's disease: what the gut can learn from other organs - a systematic review","volume":"7","author":"Bettenworth","year":"2014","journal-title":"Fibrogenes. Tissue Repair"},{"key":"B5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.maturitas.2018.01.015","article-title":"Clinical manifestations, pathophysiology, treatment and outcome of inflammatory bowel diseases in older people","volume":"110","author":"Butter","year":"2018","journal-title":"Maturitas"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3336516","DOI":"10.1155\/2022\/3336516","article-title":"Pharmacological aspects and biological effects of cannabigerol and its synthetic derivatives","volume":"2022","author":"Calapai","year":"2022","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/jgh.14119","article-title":"Crohn's disease associated strictures","volume":"33","author":"Chan","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"104862","DOI":"10.1016\/j.phrs.2020.104862","article-title":"Cutaneous endocannabinoid system: does it have a role on skin wound healing bearing fibrosis?","volume":"159","author":"Correia-S\u00e1","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/ph12020048","article-title":"Role of TRPV1 and TRPA1 ion channels in inflammatory bowel diseases: potential therapeutic targets?","volume":"12","author":"Csek\u0151","year":"2019","journal-title":"Pharm. (Basel)."},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028159","article-title":"Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis","author":"De Filippis","year":"2011"},{"key":"B11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.lfs.2005.05.055","article-title":"Cannabinoid signalling","volume":"78","author":"Demuth","year":"2006","journal-title":"Life Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0171093","DOI":"10.1371\/journal.pone.0171093","article-title":"Role of glycogen synthase kinase-3\u03b2 and PPAR-\u03b3 on epithelial-to-mesenchymal transition in DSS-Induced colorectal fibrosis","volume":"12","author":"Di Gregorio","year":"2017","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/mi.2011.18","article-title":"The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease","volume":"4","author":"Di Sabatino","year":"2011","journal-title":"Mucosal Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1365-2036.2005.02648.x","article-title":"Review article: endocannabinoids and their receptors in the enteric nervous system","volume":"22","author":"Duncan","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1053\/j.gastro.2019.05.072","article-title":"Challenges in the pathophysiology, diagnosis, and management of intestinal fibrosis in inflammatory bowel disease","volume":"162","author":"D\u2019Haens","year":"2022","journal-title":"Gastroenterology"},{"key":"B16","first-page":"89","article-title":"Mice lacking cannabinoid CB1-CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-Induced colitis","volume":"61","author":"Engel","year":"2010","journal-title":"J. Physiol. Pharmacol."},{"key":"B17","first-page":"714","article-title":"Role of PDGFR-\u03b2\/PI3K\/AKT signaling pathway in PDGF-BB induced myocardial fibrosis in rats","volume":"6","author":"Fan","year":"2014","journal-title":"Am. J. Transl. Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1053\/j.gastro.2013.07.041","article-title":"Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies","volume":"145","author":"Frolkis","year":"2013","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/ajg.2014.297","article-title":"Cumulative incidence of second intestinal resection in Crohn\u2019s disease: a systematic review and meta-Analysis of population-based studies","volume":"109","author":"Frolkis","year":"2014","journal-title":"Am. J. Gastroenterology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.3390\/ijms23105427","article-title":"Molecular and biochemical mechanism of cannabidiol in the management of the inflammatory and oxidative processes associated with endometriosis","volume":"23","author":"Genovese","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2174\/156652409787847164","article-title":"Molecular aspects of intestinal radiation-induced fibrosis","volume":"9","author":"Gervaz","year":"2009","journal-title":"Curr. Mol. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1097\/MIB.0000000000000863","article-title":"Anti-MMP-9 antibody: a promising therapeutic strategy for treatment of inflammatory bowel disease complications with fibrosis","volume":"22","author":"Goffin","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1136\/annrheumdis-2011-200314","article-title":"Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis","volume":"71","author":"Gonzalez","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"14156","DOI":"10.3390\/ijms232214156","article-title":"The PPAR\u03b1 regulation of the gut physiology in regard to interaction with microbiota, intestinal immunity, metabolism, and permeability","volume":"23","author":"Grabacka","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3760\/cma.j.issn.1007-3418.2017.11.008","article-title":"Effect of cannabinoid receptor-2 agonist AM1241 on platelet-derived growth factor expression in the liver tissue of mice with hepatic fibrosis","volume":"25","author":"He","year":"2017","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.3748\/wjg.v24.i35.4036","article-title":"Daikenchuto (Da-Jian-Zhong-Tang) ameliorates intestinal fibrosis by activating myofibroblast transient receptor potential ankyrin 1 channel","volume":"24","author":"Hiraishi","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","article-title":"New insights into TGF-\u03b2\/Smad signaling in tissue fibrosis","volume":"292","author":"Hu","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"B28","doi-asserted-by":"publisher","first-page":"21224","DOI":"10.1002\/jcp.28728","article-title":"Cannabidiol protects livers against nonalcoholic steatohepatitis induced by high\u2010fat high cholesterol diet via regulating NF\u2010\u03baB and NLRP3 inflammasome pathway","volume":"234","author":"Huang","year":"2019","journal-title":"J. Cell Physiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pharmthera.2009.12.005","article-title":"Cannabinoids and the gut: new developments and emerging concepts","volume":"126","author":"Izzo","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mam.2017.11.008","article-title":"PDGF in organ fibrosis","volume":"62","author":"Klinkhammer","year":"2018","journal-title":"Mol. Asp. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"062005","DOI":"10.1088\/1748-605X\/ac2b79","article-title":"Collagen crosslinking: effect on structure, mechanics and fibrosis progression","volume":"16","author":"Kong","year":"2021","journal-title":"Biomed. Mater. (Bristol)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"166753","DOI":"10.1016\/j.bbadis.2023.166753","article-title":"Cannabidiol alleviates right ventricular fibrosis by inhibiting the transforming growth factor \u03b2 pathway in monocrotaline-induced pulmonary hypertension in rats","volume":"1869","author":"Krzy\u017cewska","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1677\/ERC-10-0009","article-title":"Inhibition of 3-hydroxy-3-methylglutarylcoenzyme a reductase activity and of ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells","volume":"17","author":"Laezza","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3109\/00365521.2014.968863","article-title":"Mechanisms of initiation and progression of intestinal fibrosis in IBD","volume":"50","author":"Latella","year":"2015","journal-title":"Scand. J. Gastroenterol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.3892\/mmr.2016.4961","article-title":"Cannabinoid CB\u2082 receptors are involved in the regulation of fibrogenesis during skin wound repair in mice","volume":"13","author":"Li","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.trsl.2019.03.005","article-title":"Pathogenesis of fibrostenosing Crohn\u2019s disease","volume":"209","author":"Li","year":"2019","journal-title":"Transl. Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.1038\/cddis.2011.52","article-title":"Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis","volume":"2","author":"Lim","year":"2011","journal-title":"Cell Death Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.3892\/etm.2019.8045","article-title":"Pirfenidone activates cannabinoid receptor 2 in a mouse model of bleomycin-induced pulmonary fibrosis","volume":"18","author":"Liu","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"9472","DOI":"10.3390\/ijms22179472","article-title":"The endocannabinoid system: a potential target for the treatment of various diseases","volume":"22","author":"Lowe","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1002\/art.27642","article-title":"Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis","volume":"62","author":"Marquart","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e6893","DOI":"10.1371\/journal.pone.0006893","article-title":"Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue","volume":"4","author":"Marqu\u00e9z","year":"2009","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1172\/JCI19465","article-title":"The endogenous cannabinoid system protects against colonic inflammation","volume":"113","author":"Massa","year":"2004","journal-title":"J. Clin. Investigation"},{"key":"B43","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrn3811","article-title":"Early phytocannabinoid chemistry to endocannabinoids and beyond","volume":"15","author":"Mechoulam","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1124\/jpet.107.131896","article-title":"Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats","volume":"324","author":"Mu\u00f1oz-Luque","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O'Sullivan","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"G653","DOI":"10.1152\/ajpgi.2000.279.4.G653","article-title":"Fibrogenesis IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models","volume":"279","author":"Pucilowska","year":"2000","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11894-003-0015-9","article-title":"Stellate cells in the digestive tract","volume":"5","author":"Reynaert","year":"2003","journal-title":"Curr. Gastroenterol. Rep."},{"key":"B49","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1053\/j.gastro.2016.09.047","article-title":"Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases","volume":"152","author":"Rieder","year":"2017","journal-title":"Gastroenterology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1038\/emboj.2011.139","article-title":"AT1R-CB\u2081R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II","volume":"30","author":"Rozenfeld","year":"2011","journal-title":"EMBO J."},{"key":"B51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/B978-0-12-800756-3.00056-9","article-title":"Cannabis and cannabinoids and the effects on gastrointestinal function: an overview","volume-title":"Handbook of cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment","author":"Sa\u0142aga","year":"2017"},{"key":"B52","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/cells11030429","article-title":"Therapeutic targeting of intestinal fibrosis in crohn's disease","volume":"11","author":"Santacroce","year":"2022","journal-title":"Cells"},{"key":"B53","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00109-008-0359-6","article-title":"Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors","volume":"86","author":"Storr","year":"2008","journal-title":"J. Mol. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nm1421","article-title":"CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis","volume":"12","author":"Teixeira-Clerc","year":"2006","journal-title":"Nat. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2016","journal-title":"Lancet"},{"key":"B56","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bcp.2018.07.048","article-title":"Cannabinoid pharmacology and therapy in gut disorders","volume":"157","author":"Uranga","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"E928","DOI":"10.1073\/pnas.1301100110","article-title":"Unraveling the signaling pathways promoting fibrosis in Dupuytren\u2019s disease reveals TNF as a therapeutic target","volume":"110","author":"Verjee","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B58","doi-asserted-by":"publisher","first-page":"835005","DOI":"10.3389\/fimmu.2022.835005","article-title":"Intestinal fibrosis in inflammatory bowel disease and the prospects of mesenchymal stem cell therapy","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1155\/2012\/628268","article-title":"Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats","volume":"26","author":"Wengrower","year":"2012","journal-title":"Can. J. Gastroenterology"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1669951\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T04:10:33Z","timestamp":1759464633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1669951\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":59,"alternative-id":["10.3389\/fphar.2025.1669951"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1669951","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"article-number":"1669951"}}